Design and discovery of nonpeptide endothelin antagonists

  • Doherty A
  • 4


    Mendeley users who have this article in their library.
  • 29


    Citations of this article.


The involvement of the endothelin family of peptide vasoconstrictors has been implicated in a variety of human disease states. Several classes of endothelin antagonists are in early clinical development, and the therapeutic applications of this new mechanistic class of agents are beginning to emerge. This article reviews the different compound classes, their receptor selectivity for the endothelin receptor subtypes ETAand ETBand some important studies of selected compounds in animal models of different disease states.

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Annette M. Doherty

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free